Skip to main content

Table 2 Pathway enrichment analysis items of 16 LRGs from KEGG

From: Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer

ONTOLOGY

ID

Description

GeneRatio

BgRatio

P value

P.adjust

qvalue

BP

GO:0006641

triglyceride metabolic process

10/11

105/18670

2.23e-22

9.62e-20

5.50e-20

BP

GO:0006639

acylglycerol metabolic process

10/11

129/18670

1.90e-21

2.96e-19

1.69e-19

BP

GO:0006638

neutral lipid metabolic process

10/11

130/18670

2.06e-21

2.96e-19

1.69e-19

BP

GO:0019433

triglyceride catabolic process

8/11

35/18670

1.06e-20

1.14e-18

6.52e-19

BP

GO:0046461

neutral lipid catabolic process

8/11

43/18670

6.51e-20

4.68e-18

2.67e-18

MF

GO:0005504

fatty acid binding

5/11

34/17697

8.82e-12

3.53e-10

1.30e-10

MF

GO:0033293

monocarboxylic acid binding

5/11

64/17697

2.40e-10

4.79e-09

1.77e-09

MF

GO:0005324

long-chain fatty acid transporter activity

3/11

11/17697

2.94e-08

3.92e-07

1.44e-07

MF

GO:0031406

carboxylic acid binding

5/11

193/17697

6.42e-08

5.18e-07

1.91e-07

MF

GO:0036041

long-chain fatty acid binding

3/11

14/17697

6.48e-08

5.18e-07

1.91e-07

KEGG

hsa03320

PPAR signaling pathway

6/9

78/8076

5.48e-11

1.70e-09

1.50e-09

KEGG

hsa04975

Fat digestion and absorption

2/9

43/8076

9.74e-04

0.015

0.013

KEGG

hsa00561

Glycerolipid metabolism

2/9

61/8076

0.002

0.020

0.018

KEGG

hsa00564

Glycerophospholipid metabolism

2/9

98/8076

0.005

0.038

0.034

KEGG

hsa04150

mTOR signaling pathway

2/9

155/8076

0.012

0.075

0.066